SHL Telemedicine announces transformative, accretive acquisition of majority stake in Mediton Group, a leading B2B healthcare services provider in Israel

Tel Aviv / Zurich, 25 August 2021 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a
leading provider and developer of advanced personal telemedicine solutions, today announced
it has signed an agreement to acquire 70% of the Mediton Group companies. The acquisition is
accretive to SHL as of day one.

For more information, click here

Facebook
Twitter
LinkedIn
Pinterest